Virtual clinical pharmacy services: A model of care to improve medication safety in rural and remote Australian health services.
hospital pharmacy service
rural health
rural hospital
telemedicine
telepharmacy
virtual pharmacy
Journal
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
ISSN: 1535-2900
Titre abrégé: Am J Health Syst Pharm
Pays: England
ID NLM: 9503023
Informations de publication
Date de publication:
05 08 2022
05 08 2022
Historique:
pubmed:
16
3
2022
medline:
9
8
2022
entrez:
15
3
2022
Statut:
ppublish
Résumé
To describe a virtual clinical pharmacy service as a model of care to support rural and remote Australian hospitals that otherwise would not have access to onsite pharmacists. Many small hospitals in Australia do not have an onsite hospital pharmacist and struggle to support and optimize patient care. To increase access to a hospital pharmacist's specialized skills and medication knowledge, a virtual clinical pharmacy service was designed and implemented in 8 hospitals across rural New South Wales, Australia in 2020. The virtual clinical pharmacy service focuses on the core role of hospital pharmacists, including obtaining a best possible medication history, medication reconciliation at transitions of care, medication review, interprofessional team meetings, provision of patient-friendly medication lists, antimicrobial stewardship, and patient and clinician education. The model is aligned with recognized standards of practice for the delivery of clinical pharmacy services in Australian hospitals. This article details a model of care for translation across other settings. It provides the necessary details on clinical services, processes, supporting structures, an evaluation framework, and other important considerations for implementing virtual pharmacy services. This research provides policymakers, health service planners, and practitioners with a model for providing comprehensive clinical pharmacy services virtually to increase the safe and effective use of medicines. Future publication of the findings of a formal evaluation of the model's acceptability and effectiveness is planned.
Identifiants
pubmed: 35291005
pii: 6549160
doi: 10.1093/ajhp/zxac082
pmc: PMC9353697
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1376-1384Subventions
Organisme : NSW Ministry of Health Translational Research Grants Scheme
ID : FE7801
Informations de copyright
© American Society of Health-System Pharmacists 2022.
Références
Aust Health Rev. 2010 Aug;34(3):276-81
pubmed: 20797357
JMIR Res Protoc. 2019 Oct 1;8(10):e13821
pubmed: 31573933
Res Social Adm Pharm. 2021 Mar;17(3):497-505
pubmed: 32819880
Pharmacotherapy. 2002 Feb;22(2):134-47
pubmed: 11837551
BMC Health Serv Res. 2020 May 4;20(1):373
pubmed: 32366308
BMC Health Serv Res. 2021 Dec 4;21(1):1306
pubmed: 34863164